marketinsider

Join AIM ImmunoTech at the H.C. Wainwright 24th Annual Global Investment Conference: A Must-See Event for Forex Traders!

AIM ImmunoTech to Present at the H.C. Wainwright 24th Annual Global Investment Conference The Future of Cancer Treatment and Viral Diseases As AIM ImmunoTech Inc. prepares to present at the H.C. Wainwright 24th Annual Global Investment Conference, the world of immuno-pharma is buzzing with excitement. AIM is a company dedicated to researching and developing therapeutics…

Read More

Boosting Business: Finacity and ING Belgium NV Team Up to Expand Cushman & Wakefield’s Accounts Receivable Securitization Program to $200 Million

Breaking News: Accounts Receivables Securitization Program Increase to $200 Million for Cushman & Wakefield Inc. Finacity and ING Belgium NV Collaborate for Expansion STAMFORD, Conn., Sept. 06, 2022 (GLOBE NEWSWIRE) — Finacity Corporation (“Finacity”), a White Oak Company, and ING Belgium SA/NV announce that they have facilitated an increase from $125 million to $200 million…

Read More

Empowering Women’s Health: Physician Growth Partners Guides Northwestern Specialists in Partnership with Shore Capital Partners’ Portfolio Company, Together Women’s Health

Paving the way for Women’s Health in Chicagoland Physician Growth Partners Facilitates Partnership CHICAGO, Sept. 06, 2022 (GLOBE NEWSWIRE) — Physician Growth Partners (“PGP”) has announced an exciting new partnership between The Northwestern Specialists for Women (“NSW”) and Together Women’s Health (“TWH”), a portfolio company of Shore Capital Partners. This collaboration marks Together Women’s Health’s…

Read More

Unlocking the Potential: How Microscopy Devices are Revolutionizing Multiple Scientific Fields with an 8.5% CAGR Growth, According to Fact MR

Unlocking the Potential: How Microscopy Devices are Revolutionizing Multiple Scientific Fields with an 8.5% CAGR Growth, According to Fact MR Widespread Applications Across Several Scientific Disciplines Is Expected To Push The Growth Of Microscopy Devices Market By Application, Clinical Pathology And Diagnostics Is Expected To Expand 1.6x During The Forecast Period Owing To Increasing Incidence…

Read More

Breaking News: First Wave Biopharma’s AAPS 2022 PharmSci 360 Accepts Abstract for ADRULIPASE Formulation!

First Wave BioPharma Announces Exciting Development in Formulation of Microgranule Delivery for Adrulipase The Breakthrough Announcement BOCA RATON, Fla., Aug. 31, 2022 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced today that…

Read More

ASIC Warns Brokers Against Offering High-Risk Products to Retail Investors

ASIC Warns Brokers Against Offering High-Risk Products to Retail Investors Description The Australian financial market regulator issued a warning on Wednesday, asking brokers to be “careful about or reconsider” offering high-risk investment instruments or products to retail investors. Additionally, the Australian Securities & Investments Commission (ASIC) defined… Effects on Me As a retail investor, the…

Read More